(S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of PLA2G4A mRNA CTD PMID:26776438 1,2,3,4-tetrahydroisoquinoline decreases expression EXP 6480464 1 more ... CTD PMID:15683734 1,2-dimethylhydrazine decreases expression ISO Pla2g4a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of PLA2G4A mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLA2G4A mRNA CTD PMID:22206623 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] CTD PMID:18938131 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PLA2G4A mRNA CTD PMID:25380136 17beta-estradiol decreases expression ISO Pla2g4a (Mus musculus) 6480464 Estradiol results in decreased expression of PLA2G4A mRNA CTD PMID:14664709 17beta-estradiol increases expression ISO PLA2G4A (Homo sapiens) 6480464 Estradiol results in increased expression of PLA2G4A mRNA CTD PMID:36828454 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PLA2G4A mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PLA2G4A mRNA CTD PMID:30165855 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 2 more ... CTD PMID:16290172 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] more ... CTD PMID:18938131 more ... 2,3,7,8-tetrachlorodibenzodioxine increases phosphorylation ISO Pla2g4a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased phosphorylation of PLA2G4A protein CTD PMID:30790002 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO Pla2g4a (Mus musculus) 6480464 PLA2G4A protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:29043426 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pla2g4a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PLA2G4A mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases phosphorylation ISO PLA2G4A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased phosphorylation of PLA2G4A protein CTD PMID:25797602 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Pla2g4a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA and Tetrachlorodibenzodioxin results in increased expression of PLA2G4A protein CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 1 more ... CTD PMID:23583884 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA CTD PMID:23583884 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO PLA2G4A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA CTD PMID:18938131 and PMID:19162293 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Pla2g4a (Mus musculus) 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] more ... CTD PMID:19063610 more ... 2,4,4',6-tetrachlorobiphenyl multiple interactions EXP 6480464 PLA2G4A protein promotes the reaction [2 more ... CTD PMID:16120751 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO PLA2G4A (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2,6-di-tert-butyl-4-methylphenol increases expression ISO Pla2g4a (Mus musculus) 6480464 Butylated Hydroxytoluene results in increased expression of PLA2G4A protein CTD PMID:16443645 2-amino-2-deoxy-D-glucopyranose affects expression EXP 6480464 Glucosamine affects the expression of PLA2G4A mRNA CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G4A mRNA] CTD PMID:17109745 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of PLA2G4A mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of PLA2G4A mRNA CTD PMID:19643169 2-palmitoylglycerol increases expression ISO PLA2G4A (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of PLA2G4A mRNA CTD PMID:37199045 3',5'-cyclic AMP increases expression EXP 6480464 Cyclic AMP results in increased expression of PLA2G4A mRNA and Cyclic AMP results in increased expression of PLA2G4A protein CTD PMID:22187434 3',5'-cyclic AMP multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cyclic AMP results in increased expression of PLA2G4A mRNA] and 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cyclic AMP results in increased expression of PLA2G4A protein] CTD PMID:22187434 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Pla2g4a (Mus musculus) 6480464 3 more ... CTD PMID:23994337 3,3',4,4',5-pentachlorobiphenyl increases expression ISO PLA2G4A (Homo sapiens) 6480464 3 more ... CTD PMID:35618242 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 MK-886 inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] CTD PMID:9609743 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of PLA2G4A mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO Pla2g4a (Mus musculus) 6480464 bisphenol S results in increased expression of PLA2G4A mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO PLA2G4A (Homo sapiens) 6480464 bisphenol S results in increased expression of PLA2G4A protein CTD PMID:34186270 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLA2G4A mRNA CTD PMID:24835565 4-hydroxyphenyl retinamide increases expression ISO Pla2g4a (Mus musculus) 6480464 Fenretinide results in increased expression of PLA2G4A mRNA CTD PMID:28973697 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] CTD PMID:18938131 5-fluorouracil affects response to substance ISO PLA2G4A (Homo sapiens) 6480464 PLA2G4A protein affects the susceptibility to Fluorouracil CTD PMID:16217747 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases phosphorylation ISO PLA2G4A (Homo sapiens) 6480464 Omeprazole results in increased phosphorylation of PLA2G4A protein CTD PMID:25797602 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Omeprazole results in increased phosphorylation of PLA2G4A protein] CTD PMID:25797602 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PLA2G4A mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PLA2G4A mRNA CTD PMID:30047161 6alpha-methylprednisolone multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Methylprednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] CTD PMID:20573295 AACOCF3 multiple interactions ISO Pla2g4a (Mus musculus) 6480464 arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PLA2G4A protein] CTD PMID:19063610 AACOCF3 multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] CTD PMID:18938131 and PMID:19162293 acetamide increases expression EXP 6480464 acetamide results in increased expression of PLA2G4A mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO Pla2g4a (Mus musculus) 6480464 Aspirin results in decreased expression of PLA2G4A mRNA CTD PMID:10706128 aflatoxin B1 increases methylation ISO PLA2G4A (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of PLA2G4A gene CTD PMID:27153756 aldehydo-D-glucosamine affects expression EXP 6480464 Glucosamine affects the expression of PLA2G4A mRNA CTD PMID:17109745 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G4A mRNA] CTD PMID:17109745 all-trans-retinoic acid increases expression ISO PLA2G4A (Homo sapiens) 6480464 Tretinoin results in increased expression of PLA2G4A mRNA CTD PMID:21934132 and PMID:33167477 all-trans-retinoic acid multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of PLA2G4A mRNA CTD PMID:30951980 aluminium sulfate (anhydrous) increases expression ISO PLA2G4A (Homo sapiens) 6480464 aluminum sulfate results in increased expression of PLA2G4A mRNA CTD PMID:15961160 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of PLA2G4A mRNA CTD PMID:22291062 amitrole increases expression EXP 6480464 Amitrole results in increased expression of PLA2G4A mRNA CTD PMID:30047161 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of PLA2G4A mRNA CTD PMID:30779732 arachidonic acid multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 AHR affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [PLA2G4A protein results in increased secretion of Arachidonic Acid]] more ... CTD PMID:15878913 and PMID:19162293 arachidonic acid multiple interactions EXP 6480464 PLA2G4A protein promotes the reaction [2 more ... CTD PMID:16120751 arachidonic acid increases expression ISO PLA2G4A (Homo sapiens) 6480464 Arachidonic Acid results in increased expression of PLA2G4A mRNA and Arachidonic Acid results in increased expression of PLA2G4A protein CTD PMID:15878913 arsenite(3-) decreases expression ISO PLA2G4A (Homo sapiens) 6480464 arsenite results in decreased expression of PLA2G4A mRNA CTD PMID:23974009 arsenite(3-) multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to PLA2G4A mRNA] CTD PMID:32406909 arsenous acid increases expression ISO Pla2g4a (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of PLA2G4A mRNA CTD PMID:24831965 ATP increases activity ISO Pla2g4a (Mus musculus) 6480464 Adenosine Triphosphate results in increased activity of PLA2G4A protein CTD PMID:10535451 beclomethasone decreases activity ISO PLA2G4A (Homo sapiens) 6480464 Beclomethasone results in decreased activity of PLA2G4A protein CTD PMID:15337628 beclomethasone multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] CTD PMID:20573295 belinostat increases expression ISO PLA2G4A (Homo sapiens) 6480464 belinostat results in increased expression of PLA2G4A mRNA CTD PMID:26272509 belinostat multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 benzene affects expression EXP 6480464 Benzene affects the expression of PLA2G4A mRNA CTD PMID:15878777 benzene decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Benzene results in decreased expression of PLA2G4A mRNA CTD PMID:33064461 benzo[a]pyrene increases expression ISO PLA2G4A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of PLA2G4A mRNA CTD PMID:20064835 benzo[a]pyrene decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PLA2G4A mRNA CTD PMID:22316170 benzo[b]fluoranthene decreases expression ISO PLA2G4A (Homo sapiens) 6480464 benzo(b)fluoranthene results in decreased expression of PLA2G4A mRNA CTD PMID:25956473 beta-D-glucosamine affects expression EXP 6480464 Glucosamine affects the expression of PLA2G4A mRNA CTD PMID:17109745 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G4A mRNA] CTD PMID:17109745 beta-D-glucosamine 6-sulfate multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] and glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A protein] CTD PMID:21877189 beta-naphthoflavone increases expression ISO Pla2g4a (Mus musculus) 6480464 beta-Naphthoflavone results in increased expression of PLA2G4A mRNA CTD PMID:23994337 bisphenol A increases expression ISO PLA2G4A (Homo sapiens) 6480464 bisphenol A results in increased expression of PLA2G4A mRNA CTD PMID:31715268 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLA2G4A mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of PLA2G4A mRNA CTD PMID:30951980 bisphenol A increases expression ISO Pla2g4a (Mus musculus) 6480464 bisphenol A results in increased expression of PLA2G4A mRNA CTD PMID:30951980 bisphenol A increases phosphorylation ISO Pla2g4a (Mus musculus) 6480464 bisphenol A results in increased phosphorylation of PLA2G4A protein CTD PMID:30609183 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLA2G4A gene CTD PMID:28505145 bisphenol F increases expression ISO Pla2g4a (Mus musculus) 6480464 bisphenol F results in increased expression of PLA2G4A mRNA CTD PMID:30951980 budesonide decreases activity ISO PLA2G4A (Homo sapiens) 6480464 Budesonide results in decreased activity of PLA2G4A protein CTD PMID:15337628 cadmium atom increases phosphorylation ISO Pla2g4a (Mus musculus) 6480464 Cadmium results in increased phosphorylation of PLA2G4A protein CTD PMID:15212812 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of PLA2G4A mRNA CTD PMID:25808797 cadmium atom multiple interactions ISO Pla2g4a (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased phosphorylation of PLA2G4A protein] and [Cadmium results in increased activity of PLA2G4A protein] which results in increased abundance of Dinoprostone CTD PMID:15212812 cadmium atom increases activity ISO Pla2g4a (Mus musculus) 6480464 Cadmium results in increased activity of PLA2G4A protein CTD PMID:15212812 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PLA2G4A mRNA CTD PMID:33453195 cadmium sulfate multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of PLA2G4A mRNA CTD PMID:18654764 cadmium sulfate multiple interactions ISO Pla2g4a (Mus musculus) 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PLA2G4A mRNA] CTD PMID:16221973 capsaicin multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 SB 203580 inhibits the reaction [Capsaicin results in increased phosphorylation of PLA2G4A protein] CTD PMID:19959817 capsaicin increases phosphorylation ISO PLA2G4A (Homo sapiens) 6480464 Capsaicin results in increased phosphorylation of PLA2G4A protein CTD PMID:19959817 carbamazepine decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Carbamazepine results in decreased expression of PLA2G4A mRNA and Carbamazepine results in decreased expression of PLA2G4A protein CTD PMID:15312812 carbamazepine increases expression ISO Pla2g4a (Mus musculus) 6480464 Carbamazepine results in increased expression of PLA2G4A mRNA and Carbamazepine results in increased expression of PLA2G4A protein CTD PMID:17594078 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of PLA2G4A mRNA CTD PMID:20211217 carbon nanotube affects expression ISO Pla2g4a (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of PLA2G4A mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Pla2g4a (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of PLA2G4A mRNA CTD PMID:25554681 celecoxib multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [Celecoxib co-treated with docetaxel] results in decreased expression of PLA2G4A protein and Celecoxib inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] CTD PMID:15816863 and PMID:16052515 chlordecone increases expression ISO Pla2g4a (Mus musculus) 6480464 Chlordecone results in increased expression of PLA2G4A mRNA CTD PMID:33711761 chlorothalonil multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of PLA2G4A mRNA CTD PMID:33246813 choline multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLA2G4A mRNA CTD PMID:20938992 chromium(6+) affects expression ISO Pla2g4a (Mus musculus) 6480464 chromium hexavalent ion affects the expression of PLA2G4A mRNA CTD PMID:28472532 cisplatin increases expression ISO Pla2g4a (Mus musculus) 6480464 Cisplatin results in increased expression of PLA2G4A mRNA CTD PMID:15464296 and PMID:15471895 cisplatin decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Cisplatin results in decreased expression of PLA2G4A mRNA CTD PMID:27392435 cobalt dichloride multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of PLA2G4A mRNA CTD PMID:18654764 cobalt dichloride decreases expression ISO PLA2G4A (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of PLA2G4A mRNA CTD PMID:19376846 copper atom multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PLA2G4A mRNA CTD PMID:30911355 copper(0) multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PLA2G4A mRNA CTD PMID:30911355 cycloheximide multiple interactions ISO Pla2g4a (Mus musculus) 6480464 Cycloheximide inhibits the reaction [Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein]] CTD PMID:10874129 cyclophosphamide increases expression ISO Pla2g4a (Mus musculus) 6480464 Cyclophosphamide results in increased expression of PLA2G4A mRNA CTD PMID:21041162 cyclosporin A decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PLA2G4A mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Dexamethasone inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] and Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] CTD PMID:20573295 and PMID:9609743 dexamethasone decreases activity ISO Pla2g4a (Mus musculus) 6480464 Dexamethasone results in decreased activity of PLA2G4A protein CTD PMID:10874129 dexamethasone decreases expression ISO Pla2g4a (Mus musculus) 6480464 Dexamethasone results in decreased expression of PLA2G4A mRNA and Dexamethasone results in decreased expression of PLA2G4A protein CTD PMID:10874129 dexamethasone multiple interactions ISO Pla2g4a (Mus musculus) 6480464 Cycloheximide inhibits the reaction [Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein]] more ... CTD PMID:10874129 dextran sulfate increases phosphorylation ISO Pla2g4a (Mus musculus) 6480464 Dextran Sulfate results in increased phosphorylation of PLA2G4A protein CTD PMID:30142311 dextran sulfate multiple interactions ISO Pla2g4a (Mus musculus) 6480464 tussilagone inhibits the reaction [Dextran Sulfate results in increased phosphorylation of PLA2G4A protein] CTD PMID:30142311 diarsenic trioxide increases expression ISO Pla2g4a (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of PLA2G4A mRNA CTD PMID:24831965 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PLA2G4A mRNA CTD PMID:21266533 diethyldithiocarbamic acid increases expression EXP 6480464 Ditiocarb results in increased expression of PLA2G4A mRNA and Ditiocarb results in increased expression of PLA2G4A protein CTD PMID:16603213 diethyldithiocarbamic acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] more ... CTD PMID:16603213 dioxygen decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of PLA2G4A mRNA CTD PMID:26516004 diphenhydramine multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Diphenhydramine inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] CTD PMID:9609743 dorsomorphin multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PLA2G4A mRNA CTD PMID:20211217 doxorubicin decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Doxorubicin results in decreased expression of PLA2G4A mRNA CTD PMID:29803840 doxorubicin increases expression ISO Pla2g4a (Mus musculus) 6480464 Doxorubicin results in increased expression of PLA2G4A mRNA CTD PMID:26873546 entinostat increases expression ISO PLA2G4A (Homo sapiens) 6480464 entinostat results in increased expression of PLA2G4A mRNA CTD PMID:26272509 entinostat multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 ethanol multiple interactions EXP 6480464 Docosahexaenoic Acids inhibits the reaction [Ethanol results in increased expression of and results in increased phosphorylation of PLA2G4A protein] more ... CTD PMID:25029343 and PMID:29339456 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PLA2G4A protein CTD PMID:29339456 fluoranthene multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLA2G4A mRNA and [1-methylanthracene co-treated with fluoranthene] results in increased phosphorylation of and results in increased activity of PLA2G4A protein CTD PMID:28329830 and PMID:30690640 fluoxetine multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [[Fluoxetine binds to and results in increased activity of HTR2B protein] which results in increased activity of MAPK1 protein] which results in increased expression of PLA2G4A protein more ... CTD PMID:19662385 fluoxetine increases expression ISO Pla2g4a (Mus musculus) 6480464 Fluoxetine results in increased expression of PLA2G4A mRNA and Fluoxetine results in increased expression of PLA2G4A protein CTD PMID:19662385 flurbiprofen multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of PLA2G4A mRNA] CTD PMID:15878913 fluticasone affects localization ISO PLA2G4A (Homo sapiens) 6480464 Fluticasone affects the localization of PLA2G4A protein CTD PMID:15753895 folic acid multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of PLA2G4A mRNA CTD PMID:18499655 FR900359 affects phosphorylation ISO PLA2G4A (Homo sapiens) 6480464 FR900359 affects the phosphorylation of PLA2G4A protein CTD PMID:37730182 genistein affects expression ISO PLA2G4A (Homo sapiens) 6480464 Genistein affects the expression of PLA2G4A mRNA CTD PMID:22228119 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PLA2G4A mRNA CTD PMID:33387578 histamine multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Dexamethasone inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] more ... CTD PMID:9609743 histamine increases expression ISO PLA2G4A (Homo sapiens) 6480464 Histamine results in increased expression of PLA2G4A mRNA CTD PMID:9609743 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of PLA2G4A mRNA CTD PMID:15683734 hydrogen peroxide multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 hydrogen peroxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PLA2G4A mRNA] more ... CTD PMID:15683734 icosanoid multiple interactions ISO Pla2g4a (Mus musculus) 6480464 PLA2G4A protein promotes the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] CTD PMID:17369491 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of PLA2G4A mRNA CTD PMID:19821111 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of PLA2G4A mRNA CTD PMID:19821111 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of PLA2G4A mRNA CTD PMID:20211217 L-methionine multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLA2G4A mRNA CTD PMID:20938992 lead nitrate multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone] more ... CTD PMID:20850495 lead nitrate increases expression ISO PLA2G4A (Homo sapiens) 6480464 lead nitrate results in increased expression of PLA2G4A mRNA CTD PMID:20850495 lead(II) chloride multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of PLA2G4A mRNA CTD PMID:18654764 leukotriene B4 multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 PLA2G4A protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased metabolism of Leukotriene B4] and PLA2G4A protein promotes the reaction [Zymosan analog results in increased metabolism of Leukotriene B4] CTD PMID:11741884 Licochalcone B decreases expression ISO PLA2G4A (Homo sapiens) 6480464 licochalcone B results in decreased expression of PLA2G4A mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO Pla2g4a (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of PLA2G4A mRNA CTD PMID:29248447 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PLA2G4A protein CTD PMID:16842873 lipopolysaccharide multiple interactions ISO Pla2g4a (Mus musculus) 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] more ... CTD PMID:10874129 more ... lipopolysaccharide increases expression ISO PLA2G4A (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of PLA2G4A mRNA CTD PMID:20573295 more ... lipopolysaccharide multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] more ... CTD PMID:20573295 more ... lithium atom increases expression ISO Pla2g4a (Mus musculus) 6480464 Lithium results in increased expression of PLA2G4A mRNA and Lithium results in increased expression of PLA2G4A protein CTD PMID:17594078 lithium carbonate increases expression ISO Pla2g4a (Mus musculus) 6480464 Lithium Carbonate results in increased expression of PLA2G4A mRNA and Lithium Carbonate results in increased expression of PLA2G4A protein CTD PMID:17594078 lithium hydride increases expression ISO Pla2g4a (Mus musculus) 6480464 Lithium results in increased expression of PLA2G4A mRNA and Lithium results in increased expression of PLA2G4A protein CTD PMID:17594078 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of PLA2G4A mRNA CTD PMID:20578043 melittin decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Melitten results in decreased expression of PLA2G4A protein CTD PMID:21456063 mercury dibromide increases expression ISO PLA2G4A (Homo sapiens) 6480464 mercuric bromide results in increased expression of PLA2G4A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 methimazole increases expression EXP 6480464 Methimazole results in increased expression of PLA2G4A mRNA CTD PMID:30047161 methotrexate decreases expression ISO Pla2g4a (Mus musculus) 6480464 Methotrexate results in decreased expression of PLA2G4A mRNA CTD PMID:23836430 methyl methanesulfonate decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of PLA2G4A mRNA CTD PMID:23649840 methylseleninic acid increases expression ISO PLA2G4A (Homo sapiens) 6480464 methylselenic acid results in increased expression of PLA2G4A mRNA CTD PMID:18548127 N'-Nitrosonornicotine increases expression EXP 6480464 N'-nitrosonornicotine results in increased expression of PLA2G4A mRNA CTD PMID:24835565 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] CTD PMID:18938131 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] and Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PLA2G4A mRNA] CTD PMID:15683734 and PMID:16603213 N-Acetyl-S-(1,2-dichlorovinyl)-cysteine affects expression ISO PLA2G4A (Homo sapiens) 6480464 S-1 and 2-dichlorovinyl-N-acetylcysteine affects the expression of PLA2G4A mRNA CTD PMID:16844155 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 PLA2G4A protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased metabolism of Leukotriene B4] CTD PMID:11741884 N-methyl-4-phenylpyridinium increases expression ISO Pla2g4a (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PLA2G4A mRNA CTD PMID:20868657 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PLA2G4A mRNA CTD PMID:15683734 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PLA2G4A mRNA CTD PMID:25380136 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of PLA2G4A mRNA CTD PMID:26776438 nifedipine multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] and Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] CTD PMID:18938131 and PMID:19162293 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] CTD PMID:23583884 nitric oxide multiple interactions EXP 6480464 Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] and Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A protein] CTD PMID:16603213 okadaic acid increases expression ISO Pla2g4a (Mus musculus) 6480464 Okadaic Acid results in increased expression of PLA2G4A mRNA CTD PMID:25270620 olaparib multiple interactions EXP 6480464 olaparib inhibits the reaction [Ethanol results in increased expression of PLA2G4A protein] CTD PMID:29339456 omeprazole increases phosphorylation ISO PLA2G4A (Homo sapiens) 6480464 Omeprazole results in increased phosphorylation of PLA2G4A protein CTD PMID:25797602 omeprazole multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Omeprazole results in increased phosphorylation of PLA2G4A protein] CTD PMID:25797602 orientin multiple interactions ISO Pla2g4a (Mus musculus) 6480464 orientin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A protein] CTD PMID:32044341 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PLA2G4A mRNA CTD PMID:25729387 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of PLA2G4A mRNA CTD PMID:23439660 ozone multiple interactions ISO Pla2g4a (Mus musculus) 6480464 SOD1 protein inhibits the reaction [Ozone results in increased expression of PLA2G4A protein] CTD PMID:12855403 ozone increases expression ISO Pla2g4a (Mus musculus) 6480464 Ozone results in increased expression of PLA2G4A protein CTD PMID:12855403 p-chloromercuribenzoic acid increases expression ISO PLA2G4A (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of PLA2G4A mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 panobinostat multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 panobinostat increases expression ISO PLA2G4A (Homo sapiens) 6480464 panobinostat results in increased expression of PLA2G4A mRNA CTD PMID:26272509 paracetamol decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PLA2G4A mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLA2G4A mRNA CTD PMID:33387578 phenylmercury acetate increases expression ISO PLA2G4A (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of PLA2G4A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases phosphorylation ISO Pla2g4a (Mus musculus) 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of PLA2G4A protein CTD PMID:10874129 prednisolone multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 Prednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] CTD PMID:20573295 procymidone increases expression ISO Pla2g4a (Mus musculus) 6480464 procymidone results in increased expression of PLA2G4A mRNA CTD PMID:33246813 procymidone affects expression ISO Pla2g4a (Mus musculus) 6480464 procymidone affects the expression of PLA2G4A mRNA CTD PMID:36764477 procymidone multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of PLA2G4A mRNA CTD PMID:33246813 progesterone increases expression ISO PLA2G4A (Homo sapiens) 6480464 Progesterone results in increased expression of PLA2G4A mRNA CTD PMID:18070364 prostaglandin E2 multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone] more ... CTD PMID:15878913 and PMID:20850495 prostaglandin E2 multiple interactions ISO Pla2g4a (Mus musculus) 6480464 [Cadmium results in increased activity of PLA2G4A protein] which results in increased abundance of Dinoprostone CTD PMID:15212812 resveratrol increases expression ISO Pla2g4a (Mus musculus) 6480464 resveratrol results in increased expression of PLA2G4A protein CTD PMID:25505154 resveratrol multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PLA2G4A mRNA CTD PMID:23557933 rofecoxib multiple interactions ISO Pla2g4a (Mus musculus) 6480464 rofecoxib inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] CTD PMID:15816863 SB 203580 multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 SB 203580 inhibits the reaction [Capsaicin results in increased phosphorylation of PLA2G4A protein] CTD PMID:19959817 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Hydrogen Peroxide results in decreased expression of PLA2G4A mRNA] CTD PMID:15683734 SB 431542 multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of PLA2G4A mRNA and Silicon Dioxide results in decreased expression of PLA2G4A mRNA CTD PMID:25895662 and PMID:28425640 silicon dioxide increases expression ISO PLA2G4A (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of PLA2G4A mRNA CTD PMID:23623845 sodium arsenite increases expression ISO PLA2G4A (Homo sapiens) 6480464 sodium arsenite results in increased expression of PLA2G4A mRNA CTD PMID:22714537 and PMID:28595984 sodium arsenite affects expression ISO PLA2G4A (Homo sapiens) 6480464 sodium arsenite affects the expression of PLA2G4A mRNA CTD PMID:34032870 sodium arsenite increases expression ISO Pla2g4a (Mus musculus) 6480464 sodium arsenite results in increased expression of PLA2G4A protein CTD PMID:29044176 sodium arsenite decreases expression ISO Pla2g4a (Mus musculus) 6480464 sodium arsenite results in decreased expression of PLA2G4A mRNA CTD PMID:25065748 sodium chloride multiple interactions EXP 6480464 [AGT protein co-treated with Sodium Chloride] affects the expression of PLA2G4A mRNA and [AGT protein co-treated with Sodium Chloride] affects the expression of PLA2G4A protein CTD PMID:27225954 sodium chloride increases expression ISO PLA2G4A (Homo sapiens) 6480464 Sodium Chloride results in increased expression of PLA2G4A mRNA CTD PMID:23634900 sodium dodecyl sulfate decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in decreased expression of PLA2G4A mRNA CTD PMID:31734321 Soman increases expression EXP 6480464 Soman results in increased expression of PLA2G4A mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of PLA2G4A mRNA CTD PMID:30047161 sulindac multiple interactions ISO Pla2g4a (Mus musculus) 6480464 Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] CTD PMID:15816863 sulindac decreases expression ISO Pla2g4a (Mus musculus) 6480464 Sulindac results in decreased expression of PLA2G4A mRNA CTD PMID:10706128 tamoxifen decreases response to substance ISO PLA2G4A (Homo sapiens) 6480464 PLA2G4A mRNA results in decreased susceptibility to Tamoxifen CTD PMID:21119660 temozolomide decreases expression ISO PLA2G4A (Homo sapiens) 6480464 Temozolomide results in decreased expression of PLA2G4A mRNA CTD PMID:31758290 terephthalic acid increases expression EXP 6480464 terephthalic acid results in increased expression of PLA2G4A mRNA CTD PMID:16621493 tert-butyl hydroperoxide increases expression ISO PLA2G4A (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of PLA2G4A mRNA CTD PMID:15336504 tetrachloromethane affects expression ISO Pla2g4a (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of PLA2G4A mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO Pla2g4a (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of PLA2G4A mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PLA2G4A mRNA CTD PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PLA2G4A mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PLA2G4A mRNA CTD PMID:25729387 triamcinolone acetonide decreases activity ISO PLA2G4A (Homo sapiens) 6480464 Triamcinolone Acetonide results in decreased activity of PLA2G4A protein CTD PMID:15337628 trichostatin A multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 trichostatin A increases expression ISO PLA2G4A (Homo sapiens) 6480464 trichostatin A results in increased expression of PLA2G4A mRNA CTD PMID:24935251 more ... triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of PLA2G4A mRNA CTD PMID:30589522 triptonide affects expression ISO Pla2g4a (Mus musculus) 6480464 triptonide affects the expression of PLA2G4A mRNA CTD PMID:33045310 troglitazone decreases expression ISO PLA2G4A (Homo sapiens) 6480464 troglitazone results in decreased expression of PLA2G4A mRNA CTD PMID:18155510 tyrphostin AG 1478 multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone] and RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA] CTD PMID:20850495 tyrphostin AG 1478 multiple interactions ISO Pla2g4a (Mus musculus) 6480464 RTKI cpd inhibits the reaction [Fluoxetine results in increased expression of PLA2G4A mRNA] and RTKI cpd inhibits the reaction [Fluoxetine results in increased expression of PLA2G4A protein] CTD PMID:19662385 valproic acid increases expression ISO Pla2g4a (Mus musculus) 6480464 Valproic Acid results in increased expression of PLA2G4A mRNA and Valproic Acid results in increased expression of PLA2G4A protein CTD PMID:17594078 valproic acid increases expression ISO PLA2G4A (Homo sapiens) 6480464 Valproic Acid results in increased expression of PLA2G4A mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 valproic acid affects expression ISO PLA2G4A (Homo sapiens) 6480464 Valproic Acid affects the expression of PLA2G4A mRNA CTD PMID:25979313 vancomycin decreases expression ISO Pla2g4a (Mus musculus) 6480464 Vancomycin results in decreased expression of PLA2G4A mRNA CTD PMID:18930951 vorinostat multiple interactions ISO PLA2G4A (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA CTD PMID:27188386 vorinostat increases expression ISO PLA2G4A (Homo sapiens) 6480464 vorinostat results in increased expression of PLA2G4A mRNA CTD PMID:26272509 and PMID:27188386 zinc atom increases expression EXP 6480464 Zinc results in increased expression of PLA2G4A mRNA CTD PMID:17074742 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of PLA2G4A mRNA CTD PMID:17074742 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of PLA2G4A mRNA CTD PMID:17074742